发明名称 |
Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof |
摘要 |
Described herein is the generation of Fah+/− heterozygote pigs by homologous recombination and somatic cell nuclear transfer, and a method for producing Fah−/− homozygote pigs. The Fah-deficient pigs of the disclosure can be used for a variety of research and therapeutic purposes, such as for the expansion of human hepatocytes, and as large animal models of hereditary tyrosinemia type 1, cirrhosis and hepatocellular carcinoma. |
申请公布号 |
US9000257(B2) |
申请公布日期 |
2015.04.07 |
申请号 |
US201113642213 |
申请日期 |
2011.03.23 |
申请人 |
Oregon Health & Science University;Mayo Foundation for Medical Education and Research |
发明人 |
Grompe Markus;Nyberg Scott;Lillegard Joseph;Hickey Raymond |
分类号 |
C12N5/071;G01N33/50;A01K67/027;A61K49/00;C12N15/861 |
主分类号 |
C12N5/071 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A method of expanding human hepatocytes in vivo, comprising: (i) transplanting human hepatocytes or human hepatocyte precursor cells into a Fah-deficient pig, wherein the Fah-deficient pig is administered 2-(2-nitro-4-trifluoro-methyl-benzoyl)-1,3 cyclohexanedione (NTBC) prior to transplantation at a dose sufficient to prevent liver dysfunction, and allowing the human hepatocytes to expand; or (ii) transplanting human hepatocytes or human hepatocyte precursor cells into a Fah-deficient pig fetus of a pregnant sow, wherein the sow pregnant with the Fah-deficient pig fetus is administered NTBC, and allowing the human hepatocytes to expand following birth of the Fah-deficient pig,
wherein the Fah-deficient pig or pig fetus comprises homozygous disruptions in the Fah gene such that the disruption results in loss of expression of functional FAH protein, thereby expanding the human hepatocytes. |
地址 |
Portland OR US |